Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-03 @ 1:37 AM
Study NCT ID:
NCT00002659
Status:
UNKNOWN
Last Update Posted:
2013-12-19
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Sponsor:
Matrix Pharmaceutical
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent squamous cell carcinoma of the lip and oral cavity | View |
| None | recurrent squamous cell carcinoma of the oropharynx | View |
| None | recurrent squamous cell carcinoma of the nasopharynx | View |
| None | recurrent squamous cell carcinoma of the hypopharynx | View |
| None | recurrent squamous cell carcinoma of the larynx | View |
| None | recurrent squamous cell carcinoma of the paranasal sinus and nasal … | View |